AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 157 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $79,104 | -48.7% | 18,745 | -63.1% | 0.00% | – |
Q2 2023 | $154,250 | +97.3% | 50,805 | -9.7% | 0.00% | – |
Q1 2023 | $78,186 | -29.6% | 56,250 | +1.5% | 0.00% | – |
Q4 2022 | $111,000 | -5.9% | 55,399 | -5.3% | 0.00% | – |
Q3 2022 | $118,000 | -38.5% | 58,490 | +0.0% | 0.00% | – |
Q2 2022 | $192,000 | +51.2% | 58,487 | -0.0% | 0.00% | – |
Q1 2022 | $127,000 | -55.0% | 58,489 | +0.2% | 0.00% | -100.0% |
Q4 2021 | $282,000 | -8.7% | 58,355 | +3.5% | 0.00% | 0.0% |
Q3 2021 | $309,000 | +9.2% | 56,356 | +4.4% | 0.00% | 0.0% |
Q2 2021 | $283,000 | +1.1% | 53,994 | +27.5% | 0.00% | 0.0% |
Q1 2021 | $280,000 | +67.7% | 42,357 | +16.0% | 0.00% | – |
Q4 2020 | $167,000 | -25.1% | 36,521 | -24.3% | 0.00% | -100.0% |
Q3 2020 | $223,000 | -2.2% | 48,223 | +0.3% | 0.00% | 0.0% |
Q2 2020 | $228,000 | +68.9% | 48,082 | +13.4% | 0.00% | 0.0% |
Q1 2020 | $135,000 | – | 42,384 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
PA Capital LLC | 33,874 | $132,000 | 0.09% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |